(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 38.05%-53.08M | ---- | 1.27%-85.68M | -106.10%-35.09M | -1,700.87%-86.78M | -247.51%-17.03M | -90.16%5.42M | -55.16%11.54M | -6.18%55.08M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 95.98%-15K | ---- | 52.90%-373K | -308.14%-351K | 12.49%-792K | 89.65%-86K | -33.88%-905K | -76.06%-831K | -3.21%-676K |
Attributable subsidiary (profit) loss | ---- | -94.20%36K | ---- | 309.09%621K | -36.69%214K | -253.89%-297K | --338K | --193K | ---- | ---- |
Impairment and provisions: | ---- | -35.04%21.87M | ---- | 77.08%33.67M | 983.32%20.65M | 1,719.43%19.01M | 12,806.67%1.91M | 2,422.22%1.05M | -101.90%-15K | 99.74%-45K |
-Impairment of trade receivables (reversal) | ---- | -68.89%6.34M | ---- | 36.39%20.39M | 567.42%12.72M | 1,330.43%14.95M | 1,261.43%1.91M | 248.02%1.05M | 10.24%140K | 95.91%-706K |
-Other impairments and provisions | ---- | 16.94%15.53M | ---- | 226.69%13.28M | --7.93M | --4.07M | ---- | ---- | -123.45%-155K | --661K |
Revaluation surplus: | ---- | ---- | ---- | 145.05%272K | 173.23%93K | 122.42%111K | ---127K | -22.83%-495K | ---- | ---403K |
-Other fair value changes | ---- | ---- | ---- | 145.05%272K | 173.23%93K | 122.42%111K | ---127K | -22.83%-495K | ---- | ---403K |
Asset sale loss (gain): | ---- | -98.47%10K | ---- | 2,747.83%655K | --100K | 475.00%23K | ---- | 100.81%4K | ---- | ---494K |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | --668K | --100K | ---- | ---- | ---- | ---- | ---497K |
-Loss (gain) on sale of property, machinery and equipment | ---- | 176.92%10K | ---- | -156.52%-13K | ---- | 475.00%23K | ---- | 33.33%4K | ---- | --3K |
Depreciation and amortization: | ---- | 322.96%3M | ---- | 15.26%710K | 32.58%350K | -17.87%616K | -24.57%264K | 120.59%750K | 108.33%350K | 2.41%340K |
Financial expense | ---- | 153.66%312K | ---- | 119.64%123K | 8.33%26K | -62.67%56K | -82.35%24K | -85.56%150K | -73.12%136K | 82.60%1.04M |
Special items | ---- | 101.09%1K | ---- | -248.39%-92K | -55.56%24K | 107.28%62K | 2,600.00%54K | ---852K | --2K | ---- |
Operating profit before the change of operating capital | ---- | 44.39%-27.86M | ---- | 26.32%-50.1M | 4.55%-13.99M | -1,380.19%-67.99M | -231.02%-14.65M | -90.31%5.31M | -57.37%11.18M | 31.58%54.84M |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | ---- | -832.97%-64.26M | ---- | -590.60%-6.89M | 6.75%2.47M | -81.86%1.4M | 765.71%2.31M | 128.62%7.74M | 99.02%-347K | -175.51%-27.05M |
Accounts payable increase (decrease) | ---- | 189.79%44.09M | ---- | 209.56%15.22M | -232.65%-2.44M | 152.47%4.92M | 89.85%-732K | -1,715.50%-9.37M | -157.82%-7.21M | 97.76%-516K |
prepayments (increase)decrease | ---- | -255.57%-42.14M | ---- | -23.42%27.09M | 202.42%13.85M | 170.26%35.38M | 76.30%-13.53M | 48.07%-50.35M | 34.13%-57.06M | -591.43%-96.95M |
Special items for working capital changes | ---- | 369.41%14.43M | ---- | -293.39%-5.36M | -94.11%-6.73M | 326.00%2.77M | -84.95%-3.47M | -84.90%650K | -159.12%-1.87M | --4.3M |
Cash from business operations | ---- | -278.12%-75.75M | ---- | 14.85%-20.03M | 77.28%-6.83M | 48.87%-23.53M | 45.64%-30.07M | 29.61%-46.01M | 31.00%-55.31M | -261.68%-65.37M |
Other taxs | ---- | -15.79%-66K | ---- | 97.36%-57K | 97.86%-46K | 81.91%-2.16M | 79.27%-2.15M | -284.67%-11.92M | -239.44%-10.39M | 59.93%-3.1M |
Special items of business | 19.99%-45.14M | ---- | ---56.42M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from operations | 19.99%-45.14M | -277.38%-75.82M | -720.39%-56.42M | 21.78%-20.09M | 78.66%-6.88M | 55.67%-25.68M | 50.96%-32.22M | 15.39%-57.93M | 21.06%-65.7M | -309.40%-68.47M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -66.67%5K | -95.98%15K | -95.73%15K | -52.90%373K | 308.14%351K | -12.49%792K | -89.65%86K | 33.88%905K | 76.06%831K | 3.21%676K |
Sale of fixed assets | ---- | ---- | ---- | 189.47%55K | ---- | --19K | --18K | ---- | ---- | ---- |
Purchase of fixed assets | ---- | -2,584.70%-7.2M | ---769K | 49.34%-268K | ---- | 19.60%-529K | 21.81%-502K | -189.87%-658K | -243.32%-642K | -2,422.22%-227K |
Sale of subsidiaries | ---663K | ---- | ---- | ---2.16M | ---- | ---- | ---- | ---- | ---- | --51.84M |
Acquisition of subsidiaries | --323K | ---- | ---- | ---- | ---- | ---- | ---- | ---20.4M | ---- | ---- |
Recovery of cash from investments | ---- | ---- | ---- | 0.98%13.13M | ---- | -88.55%13M | -61.76%13M | -49.20%113.56M | -84.79%34M | -22.38%223.55M |
Cash on investment | ---- | ---- | ---- | ---- | ---- | 86.05%-18.4M | 70.18%-13M | 41.01%-131.88M | 80.50%-43.6M | 22.38%-223.55M |
Other items in the investment business | 70,450.00%4.22M | ---11K | ---6K | ---- | ---- | -10.50%-2.21M | ---1.5M | ---2M | ---- | ---- |
Net cash from investment operations | 611.32%3.89M | -164.63%-7.19M | -316.52%-760K | 251.84%11.13M | 118.49%351K | 81.89%-7.33M | 79.83%-1.9M | -177.41%-40.48M | -118.06%-9.41M | 7,993.50%52.28M |
Net cash before financing | 27.85%-41.26M | -826.10%-83.01M | -776.16%-57.18M | 72.85%-8.96M | 80.87%-6.53M | 66.45%-33.01M | 54.57%-34.12M | -508.03%-98.41M | -141.51%-75.11M | -148.54%-16.19M |
Cash flow from financing activities | ||||||||||
New borrowing | -50.56%9.81M | 16.72%18.71M | 296.62%19.83M | --16.03M | --5M | ---- | ---- | ---- | ---- | ---- |
Refund | 80.80%-3.89M | ---35.09M | ---20.23M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Issuing shares | -84.93%13.29M | --130.74M | --88.18M | ---- | ---- | ---- | ---- | --154.09M | --154.09M | ---- |
Interest paid - financing | ---38K | ---214K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 24.75%-16.71M | 74.71%-4.3M | 66.62%-22.2M |
Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | --3.3M | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---332K | ---15.78M | ---- | ---- | ---- | ---- | ---- | ---37.02M | ---37.02M | ---- |
Net cash from financing operations | -80.70%16.87M | 521.96%96.86M | 1,752.31%87.39M | 4,378.30%15.57M | 47.02%4.72M | -100.36%-364K | -97.15%3.21M | 550.43%100M | 762.41%112.61M | 56.47%-22.2M |
Effect of rate | 59.17%2.46M | 33.74%2.64M | 26.27%1.54M | 219.67%1.98M | 271.15%1.22M | 69.01%-1.65M | -148.67%-714K | -38,171.43%-5.33M | 653.58%1.47M | -98.85%14K |
Net Cash | -180.71%-24.39M | 109.56%13.85M | 1,771.13%30.21M | 119.80%6.61M | 94.15%-1.81M | -2,203.09%-33.38M | -182.41%-30.91M | 104.13%1.59M | 177.97%37.5M | -117.47%-38.39M |
Begining period cash | 79.63%37.21M | 70.80%20.72M | 70.80%20.72M | -74.28%12.13M | -74.28%12.13M | -7.35%47.16M | -7.35%47.16M | -42.98%50.9M | -42.98%50.9M | -15.55%89.27M |
Cash at the end | -70.88%15.28M | 79.63%37.21M | 354.62%52.47M | 70.80%20.72M | -25.70%11.54M | -74.28%12.13M | -82.71%15.53M | -7.35%47.16M | 119.70%89.87M | -42.98%50.9M |
Cash balance analysis | ||||||||||
Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -7.35%47.16M | 119.70%89.87M | --50.9M |
Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -7.35%47.16M | 119.70%89.87M | --50.9M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data